Broad-spectrum human papillomavirus vaccines: New horizons but one step at a time

Journal of the National Cancer Institute

Volumn 101, Issue 11, 2009, Pages 771-773

  Bosch, F Xavier ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE; HUMAN PAPILLOMAVIRUS VACCINE L1, TYPE 6,11,16,18; HUMAN PAPILLOMAVIRUS VACCINE, L1 TYPE 16, 18;

CANCER PREVENTION; COST BENEFIT ANALYSIS; DRUG COST; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNOGENICITY; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; VACCINATION; ALPHAPAPILLOMAVIRUS; ANIMAL; FEMALE; IMMUNOLOGY; MASS SCREENING; PHASE 1 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; UTERINE CERVIX TUMOR; VAGINA TUMOR; VIROLOGY; VIRUS INFECTION; VULVA TUMOR;

ALPHAPAPILLOMAVIRUS; ANIMALS; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; VULVAR NEOPLASMS;

EID: 67449096293     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djp119     Document Type: Editorial

References (17)

1. Markowitz LE, Dunne EF, Saraiya M, et al. Centers for Disease Control and Prevention. Quadrivalent Human Papillomavirus Vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR (2007) 56(No. RR02). Available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm. Accessed April 2, 2009.
2. European Centre for Disease Prevention and Control (ECDC). Guidance for the introduction of HPV vaccines in European countries. 2008; Available at: http://ecdc.europa.eu/pdf/HPV-report.pdf. Accessed April 2, 2009.
3. World Health Organization. Global Advisory Committee on Vaccine Safety (GACVS), 17-18 December 2008. Weekly Epidemiological Record 84: 37-40. Available at: http://www.who.int/vaccine-safety/en/. Accessed April 2, 2009.
4. Schiller JT, Castellsagué X, Villa LL, Hildesheim A. An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results. Vaccine. 2008; 26 (10): K53-K61.
5. Centers for Disease Control and Prevention. Reports of health concerns following HPV vaccination. 2009. Available at: www.cdc.gov/vaccinesafety/vaers/ gardasil.htm. Accessed April 2, 2009.
6. Batson A, Meheus F, Brooke S. Chapter 26: innovative financing mechanisms to accelerate the introduction of HPV vaccines in developing countries. Vaccine. 2006; 24 (3): S3/219-S3/225.
7. Andrus JK, Lewis MJ, Goldie SJ, et al. Introduction of human papilloma-virus vaccines into developing countries - international strategies for funding and procurement. Vaccine. 2008; 26 (10): K87-K92.
8. Stanley M, Gissmann L, Nardelli-Haefliger D. Immunobiology of human papillomavirus infection and vaccination - implications for second generation vaccines. Vaccine. 2008; 26 (10): K62-K67.
9. Cuzick J, Arbyn M, Sankaranarayanan R, et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine. 2008; 26 (10): K29-K41.
10. Jagu S, Karanam B, Gambhira R, et al. Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines. J Natl Cancer Inst. 2009; 101 (11): 782-792.
11. Pagliusi SR, Aguado MT. Efficacy and other milestones for human papillomavirus vaccine introduction. Vaccine. 2004; 23 (5): 569-578.
12. Castellsagué X, de Sanjosé S, Aguado T, et al. HPV and cervical cancer in the World. 2007 Report. HPV Information Centre. Vaccine. 2007; 25 (3): C1-230. Available at: www.who.int/hpvcentre. Accessed April 2, 2009.
13. Sankaranarayanan R, Bhatla N, Gravitt PE, et al. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. Vaccine. 2008; 26 (12): M43-M52.
14. Qiao YL, Sellors JW, Eder PS, et al. A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China. Lancet Oncol. 2008; 9 (10): 929-936.
15. Sankaranarayanan R, Nene BM, Shastri SS, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009; 360 (14): 1453-1455.
16. Kane MA, Sherris J, Coursaget P, Aguado T, Cutts F. Chapter 15: HPV vaccine use in the developing world. Vaccine. 2006; 24 (3): S3/132-S3/139.
17. World Health Organization. Meeting of the Immunization Strategic Advisory Group of Experts, November 2008 - conclusions and recommendations. Wkly Epidemiol Rec. 84: 1-16. Available at: http://www.who.int/wer/2009/wer8401- 02.pdf. Accessed April 2, 2009.